Your browser doesn't support javascript.
loading
Prevalence of doravirine cross-resistance in HIV-infected adults who failed first-line ART in China, 2014-18.
Sun, Zhuoqun; Lan, Yun; Liang, Shujia; Wang, Jing; Ni, Mingjian; Zhang, Xia; Yu, Fengting; Chen, Meiling; Zhang, Hanxi; Yan, Liting; Cai, Weiping; Lan, Guanghua; Ma, Ye; Zhang, Fujie.
Afiliación
  • Sun Z; Peking University Ditan Teaching Hospital, Beijing, China.
  • Lan Y; Capital Medical University Affiliated Beijing Ditan Hospital, Beijing, China.
  • Liang S; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Wang J; Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China.
  • Ni M; Chongqing Public Health Medical Center, Chongqing, China.
  • Zhang X; Xinjiang Center for Disease Control and Prevention, Xinjiang, China.
  • Yu F; Medical Laboratory Science Department of Weifang Medical College, Shandong, China.
  • Chen M; Capital Medical University Affiliated Beijing Ditan Hospital, Beijing, China.
  • Zhang H; Capital Medical University Affiliated Beijing Ditan Hospital, Beijing, China.
  • Yan L; Capital Medical University Affiliated Beijing Ditan Hospital, Beijing, China.
  • Cai W; Capital Medical University Affiliated Beijing Ditan Hospital, Beijing, China.
  • Lan G; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Ma Y; Guangxi Key Laboratory of Major Infectious Disease Prevention and Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China.
  • Zhang F; National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
J Antimicrob Chemother ; 77(4): 1119-1124, 2022 03 31.
Article en En | MEDLINE | ID: mdl-35134966
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 / Fármacos Anti-VIH Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Asia Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: China